Oncology Med Bot
Answers patient questions around the clock and files a structured history to the doctor's dashboard.
Explore Oncology Med BotDetect earlier. Decide faster. Care better.
PRR.AI is a healthcare AI company. It builds four products: Oncology Med Bot for patient engagement, Computer Vision AI for digital pathology, CareLinq AI for ambient clinical documentation, and Pharma Marketing AI for pharmaceutical field teams.
HL7 and FHIR interfaces · HIPAA-aligned access controls and audit logs
Built for
Research and technology partners






Four intelligence systems that extract signal from the data your teams already generate, and turn it into action at the point of decision.
PRR.AI builds four healthcare AI products on one platform. Oncology Med Bot is an AI patient engagement platform that answers patient health questions, collects symptoms and summarises the history into the doctor's dashboard. Computer Vision AI is a digital pathology AI platform, and it includes NuGleason, a Gleason grading tool for prostate cancer, and PathVu, a whole slide image viewer. CareLinq AI is an AI medical scribe that turns doctor and patient conversations into structured notes and discharge summaries. Pharma Marketing AI is a pharma sales enablement tool that coaches medical representatives before, during and after a call.
All four connect over HL7 and FHIR. Access is controlled by role, and every action is written to an audit log. PRR.AI products support clinicians. They do not replace clinical judgement.
Answers patient questions around the clock and files a structured history to the doctor's dashboard.
Explore Oncology Med BotDigital pathology AI for detection and grading on whole slide images, plus IVF embryo scoring.
Explore Computer Vision AIAn ambient medical scribe that turns consultations into structured notes and discharge summaries.
Explore CareLinq AIBriefs, supports and coaches medical representatives before, during and after every call.
Explore Pharma Marketing AICase management, slide review and AI analysis in one place, rather than a scanner in one system and a viewer in another.
NuGleason and PathVu are named products within Computer Vision AI, each with its own dedicated page.
Digital pathology
Gleason grading for prostate cancer on whole slide images, with heatmaps and standardised reports.
NuGleason: Gleason grading AI softwareWhole slide imaging
The microscope in the browser, with annotations, multiview comparison and remote collaboration.
PathVu: whole slide image viewerHospital discharge
Builds a structured discharge summary from handwritten notes, scanned PDFs and hospital systems.
Discharge summary automationBuilt for the security, interoperability and scale that regulated healthcare demands.
Secure, real-time data access with high availability and disaster recovery.
Encryption, access controls, audit logs and regular security updates.
APIs plus HL7 and FHIR for interoperability with major healthcare systems.
Modular features that scale from a single clinic to a hospital network.
A clinician reviews the output. The tool never files a note or a grade on its own.
4
Products on one platform
HL7 / FHIR
Interface standards supported
3
Data-protection regimes addressed: HIPAA, GDPR, India DPDP
100%
Clinical output reviewed by a clinician before it is filed
PRR.AI is a healthcare AI company. It builds four products: Oncology Med Bot for patient engagement, Computer Vision AI for digital pathology, CareLinq AI for ambient clinical documentation, and Pharma Marketing AI for pharmaceutical field teams.
NuGleason is a Gleason grading tool for prostate cancer from PRR.AI. It applies AI to whole slide images for prostate cancer detection and grading, and returns heatmaps, Gleason scores and standardised reports to the pathologist. NuGleason is recognised under the NCG CATCH grant programme.
PathVu is a cloud whole slide image viewer from PRR.AI. It recreates the microscope experience in a secure browser-based viewer, supporting annotations, multiview comparison, real-time remote collaboration and AI overlays.
Yes. PRR.AI products connect through APIs and HL7 and FHIR interfaces, and support ABDM for deployments in India. Pathology deployments also interface with the laboratory information system and the image store.
Bring your interface list to the demo and we will map it against what is already built.
PRR.AI runs HIPAA-aligned controls: encryption, role-based access controls, audit logs and regular security updates. Deployments in the European Union are configured for GDPR, and deployments in India for the Digital Personal Data Protection Act.
Data residency is configured per deployment. Ask for the current compliance pack and the data-flow diagram during the demo.
No. Every PRR.AI product keeps a clinician in the loop. The pathology tools are decision support with real-time error correction by the pathologist, not stand-alone diagnostic devices, and the documentation tools produce notes that the treating clinician reviews and signs. Regulatory status differs by product and by market, so ask us for the current position for yours.
A named clinician reviews every medical claim on prr.ai before it is published, and each clinical statement carries a citation to its source. Product pages state the regulatory status of the product.
Bad health information hurts the reader, so health content is held to a higher standard than other content. We meet it in public. Four rules govern everything published on prr.ai.
Medical and technical leadership listed publicly on prr.ai:
Bring a workflow, an interface list and a compliance question. We will show you what the platform already does and what it would take to fit yours.
Request a demo